Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Muto

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Idrugs : the Investigational Drugs Journal|June 12, 2003
Recent chymase inhibitors and their effects in in vivo modelsTsuyoshi Muto, Harukazu Fukami
Bioorganic & Medicinal Chemistry|May 31, 2013
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug designTaisaku Tanaka, Hajime Sugawara, Hiroshi Maruoka, et al.
Optics Express|August 6, 2009
Surface waves in photorefractive polymer filmsTakashi Fujihara, Takafumi Sassa, Tsuyoshi Muto, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitorsHidenobu Murafuji, Hiroki Sakai, Megumi Goto, et al.
Immunology Letters|October 15, 2003
Human chymase stimulates Ca2+ signaling in human polymorphonuclear cellsKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 3, 2010
Reversible conversion of the majority carrier type in solution-processed ambipolar quinoidal oligothiophene thin filmsJean-Charles Ribierre, Satoshi Watanabe, Mutsuyoshi Matsumoto, et al.
European Journal of Pharmacology|May 26, 2019
ASB17061, a novel chymase inhibitor, prevented the development of angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient miceYoshiaki Tomimori, Atsushi Manno, Taisaku Tanaka, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Design, synthesis, and biological evaluation of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation-Use of a conformation-based hypothesis to facilitate compound designKatsushi Katayama, Tsutomu Nagata, Kouhei Takashima, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitorsHiroshi Maruoka, Tsuyoshi Muto, Taisaku Tanaka, et al.
Chemical & Pharmaceutical Bulletin|October 2, 2015
Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 InactivationBitoku Takahashi, Hideaki Funami, Makoto Shibata, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Idrugs : the Investigational Drugs Journal|June 12, 2003
Recent chymase inhibitors and their effects in in vivo modelsTsuyoshi Muto, Harukazu Fukami
Bioorganic & Medicinal Chemistry|May 31, 2013
Discovery of novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as human chymase inhibitors using structure-based drug designTaisaku Tanaka, Hajime Sugawara, Hiroshi Maruoka, et al.
Optics Express|August 6, 2009
Surface waves in photorefractive polymer filmsTakashi Fujihara, Takafumi Sassa, Tsuyoshi Muto, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitorsHidenobu Murafuji, Hiroki Sakai, Megumi Goto, et al.
Immunology Letters|October 15, 2003
Human chymase stimulates Ca2+ signaling in human polymorphonuclear cellsKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 3, 2010
Reversible conversion of the majority carrier type in solution-processed ambipolar quinoidal oligothiophene thin filmsJean-Charles Ribierre, Satoshi Watanabe, Mutsuyoshi Matsumoto, et al.
European Journal of Pharmacology|May 26, 2019
ASB17061, a novel chymase inhibitor, prevented the development of angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient miceYoshiaki Tomimori, Atsushi Manno, Taisaku Tanaka, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2020
Design, synthesis, and biological evaluation of spiroindolines as novel inducers of oligodendrocyte progenitor cell differentiation-Use of a conformation-based hypothesis to facilitate compound designKatsushi Katayama, Tsutomu Nagata, Kouhei Takashima, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitorsHiroshi Maruoka, Tsuyoshi Muto, Taisaku Tanaka, et al.
Chemical & Pharmaceutical Bulletin|October 2, 2015
Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 InactivationBitoku Takahashi, Hideaki Funami, Makoto Shibata, et al.
Pageof 4